GINGER SMITH: Open Payments
NPI 1528029972 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,000 in 45 payments from 12 companies in 2025. Trend: 2023 $818 · 2024 $861 · 2025 $1,000
Food & beverage: $883Education: $117
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $215 |
| UCB, Inc. | 5 | $147 |
| GENZYME CORPORATION | 5 | $141 |
| Janssen Biotech, Inc. | 2 | $117 |
| ABBVIE INC. | 5 | $107 |
| E.R. Squibb & Sons, L.L.C. | 5 | $90 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $48 |
| Lilly USA, LLC | 2 | $36 |
| Galderma Laboratories, L.P. | 2 | $34 |
| LEO Pharma Inc. | 1 | $28 |
Products named: CIBINQO, Bimzelx, DUPIXENT, TREMFYA, RINVOQ, Sotyktu, ILUMYA, TALTZ.
Industry payments across NC — which companies pay providers there.
